Institutional shares held 30,600
0 calls
0 puts
Total value of holdings $0
$0 calls
$0 puts
Market Cap N/A
Institutional ownership 0.1%
# of Institutions 2


Latest Institutional Activity in BCEL

Top Purchases

Q1 2024
Xtx Topco LTD Shares Held: 54.1K ($0)
Q1 2024
Assetmark, Inc Shares Held: 38 ($0)
Q4 2023
Hrt Financial LP Shares Held: 207K ($0)
Q4 2023
Susquehanna International Group, LLP Shares Held: 105K ($0)
Q4 2023
Dlk Investment Management, LLC Shares Held: 89K ($0)

Top Sells

Q1 2024
Simplex Trading, LLC Shares Held: 1 ($0)
Q4 2023
Baker Bros. Advisors LP Shares Held: 2.18M ($0)
Q4 2023
Black Rock Inc. Shares Held: 638K ($0)
Q4 2023
Vanguard Group Inc Shares Held: 909K ($0)
Q4 2023
Bridgeway Capital Management, LLC Shares Held: 75K ($0)

About BCEL

Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients. It also developing APN-122597, a receptor tyrosine kinase that target tumor tissues; and ATRC-501/MAM01, that targets the circumsporozoite protein of Plasmodium falciparum for the treatment of malaria. It has a collaboration and license agreement with Xencor, Inc. for research, development, and commercialization of novel CD3 bispecific antibodies in oncology; licensing agreement with the Bill & Melinda Gates Medical Research Institute for the development and commercialization of MAM01/ATRC-501 for the prevention of malaria. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California.


Insider Transactions at BCEL

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
1 Shares
From 1 Insiders
Open market or private purchase 1 shares
Sell / Disposition
20.8K Shares
From 1 Insiders
Open market or private sale 20.8K shares

Track Institutional and Insider Activities on BCEL

Follow Atreca, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCEL shares.

Notify only if

Insider Trading

Get notified when an Atreca, Inc. insider buys or sells BCEL shares.

Notify only if

News

Receive news related to Atreca, Inc.

Track Activities on BCEL